Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Jacobson

Showing results (11-20 of 144) with videos related to

Pageof 15
Sort By:
The American Journal of Medicine|May 31, 2001
Human immunodeficiency virus-associated immune reconstitution diseaseM A Jacobson
The American Journal of Medicine|February 14, 1992
Maintenance therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: foscarnetM A Jacobson
AIDS Clinical Review|January 1, 1992
Foscarnet therapy for AIDS-related opportunistic herpesvirus infectionsM A Jacobson
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Review of the toxicities of foscarnetM A Jacobson
AIDS Clinical Review|January 1, 1990
Ganciclovir therapy for opportunistic cytomegalovirus disease in AIDSM A Jacobson
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1995
Update (1995) on clinical trials of antiviral therapy and prophylaxis for AIDS-related cytomegalovirus diseaseM A Jacobson
Annals of Internal Medicine|April 1, 1988
Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatmentM A Jacobson, J Mills
Clinics in Chest Medicine|September 1, 1988
Cytomegalovirus infectionM A Jacobson, J Mills
AIDS (London, England)|June 20, 1998
Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapyM A Jacobson, M French
Drug Safety|July 1, 1993
Human immunodeficiency virus (HIV) infection. Does it increase susceptibility to adverse drug reactions?G E Harb, M A Jacobson
Pageof 15

Showing results (11-20 of 144) with videos related to

Sort By:
Pageof 15
The American Journal of Medicine|May 31, 2001
Human immunodeficiency virus-associated immune reconstitution diseaseM A Jacobson
The American Journal of Medicine|February 14, 1992
Maintenance therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: foscarnetM A Jacobson
AIDS Clinical Review|January 1, 1992
Foscarnet therapy for AIDS-related opportunistic herpesvirus infectionsM A Jacobson
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Review of the toxicities of foscarnetM A Jacobson
AIDS Clinical Review|January 1, 1990
Ganciclovir therapy for opportunistic cytomegalovirus disease in AIDSM A Jacobson
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1995
Update (1995) on clinical trials of antiviral therapy and prophylaxis for AIDS-related cytomegalovirus diseaseM A Jacobson
Annals of Internal Medicine|April 1, 1988
Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatmentM A Jacobson, J Mills
Clinics in Chest Medicine|September 1, 1988
Cytomegalovirus infectionM A Jacobson, J Mills
AIDS (London, England)|June 20, 1998
Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapyM A Jacobson, M French
Drug Safety|July 1, 1993
Human immunodeficiency virus (HIV) infection. Does it increase susceptibility to adverse drug reactions?G E Harb, M A Jacobson
Pageof 15